Wound Care Devices
•28 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (28)
%
| Company | Market Cap | Price |
|---|---|---|
|
Wound care devices including ALLEVYN Ag+ SURGICAL under Advanced Wound Management.
|
$15.42B |
$17.71
|
|
Wound Care Devices are a core MedSurg product line (V.A.C. Peel and Place) that Solventum markets and sells.
|
$12.91B |
$74.29
-0.42%
|
|
Wound care devices such as Hemopatch/Hemostat are core offerings in Baxter's surgical/wound management line.
|
$11.26B |
$21.95
-3.09%
|
|
QuikClot Control+ hemostatic device aligns with wound care/bleeding-control medical devices.
|
$5.28B |
$119.42
-4.53%
|
|
The safe patient handling segment is a major medical device category for UFPT, including wound care and related devices.
|
$1.50B |
$195.22
+0.25%
|
|
Wound care devices and regenerative templates (IDRT, DuraSorb) are central to Integra's Tissue Technologies segment.
|
$1.04B |
$13.34
-5.86%
|
|
Wound care devices including placental tissue allografts (EPIFIX, EPIEFFECT, HELIOGEN, EPIXPRESS) and related adjunct therapies constitute MiMedx's core product line.
|
$967.45M |
$6.55
-5.21%
|
|
Avive Soft Tissue Matrix is a tissue-healing device used in surgical wound management.
|
$728.25M |
$15.99
-2.26%
|
|
Bone growth stimulation device (AccelStim 2.0) categorized under wound care devices in the tagging schema.
|
$556.37M |
$14.20
+1.50%
|
|
Organogenesis' core wound-care offerings include wound care devices and biomaterial barriers (e.g., PuraPly family) used in wound management.
|
$502.34M |
$3.96
-2.46%
|
|
Core product category is wound care devices, a substantial and investable segment.
|
$320.66M |
$37.48
+8.92%
|
|
InfuSystem is expanding into wound care through partnerships and capabilities, including wound care devices and services.
|
$193.60M |
$9.23
-3.95%
|
|
NexoBrid and EscharEx are enzymatic debridement products used in wound care, aligning with the Wound Care Devices category.
|
$190.99M |
$18.17
+1.34%
|
|
Wound care devices align with first aid and medical product lines.
|
$145.18M |
$38.30
-0.78%
|
|
RECELL GO platform and related wound care products are sold as wound care devices/materials, fitting the Wound Care Devices category.
|
$140.50M |
$1.00
|
|
RECELL System and its related wound-care products (RECELL GO, RECELL GO mini, Cohealyx, PermeaDerm) are direct medical devices for wound care, fitting the Wound Care Devices category.
|
$135.87M |
$5.14
-6.72%
|
|
The company has wound care/regenerative biologics products used in wound healing contexts.
|
$99.70M |
$0.72
-3.30%
|
|
The DeepView platform includes wound care device capabilities, enabling assessment and management of wounds.
|
$57.42M |
$2.23
-8.79%
|
|
Biomaterial products derived from placenta (e.g., placental matrix) used in wound care are a direct Celularity offering.
|
$49.10M |
$2.05
-3.76%
|
|
Wound Care Devices captures tissue repair and regenerative biomatrix products (SimpliDerm/SimpliDerm RM) designed to aid healing and reduce inflammatory responses.
|
$36.18M |
$0.89
+1.02%
|
|
VergenixSTR soft tissue repair matrix and tissue regeneration devices fall under wound care/soft tissue repair devices.
|
$25.20M |
$2.20
-6.38%
|
|
The company leverages hydrogel-based materials for wound care applications, fitting the Wound Care Devices category.
|
$19.67M |
$2.57
-3.02%
|
|
Cuprina's MEDIFLY maggot debridement therapy and collagen/leech wound-care products are direct wound-care devices.
|
$17.28M |
$0.96
-12.73%
|
|
Wound care devices are listed among MHUA's disposable medical devices.
|
$10.18M |
$0.39
-6.47%
|
|
NovaBay's continuing operations revolve around manufacturing wound care products for export to China, making Wound Care Devices its direct current product focus.
|
$7.15M |
$1.23
-0.81%
|
|
Wound Care Devices covers non-invasive devices related to wound care and therapeutic applications, aligning with NanoVibronix's legacy wound/ultrasound products.
|
$1.63M |
$6.32
-9.71%
|
|
LockeT is related to wound care devices and faster/efficient wound closure.
|
$1.60M |
$2.76
-2.82%
|
|
Aurix System is a proprietary point-of-care wound care device used to treat chronic wounds.
|
$972618 |
$2.25
+1.46%
|
Loading industry metrics...
Loading comparison data...
